Stan Yarbro

Stan Yarbro discloses dealings in 2 companies, chiefly Varian Semiconductor Equipment Associates Inc and CALMARE THERAPEUTICS Inc. In total, 53 filings cover trades dated from 1 February 2006 to 2 January 2015.

Both buying and selling appear: 2 purchases worth €5,612, against 16 sales worth €1.7M. Netting one side against the other leaves €1.7M of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 25 share grants and 10 option exercises.

Most recently, on 1 June 2015, the filings show a share grant in CALMARE THERAPEUTICS Inc. The last purchase on record was published on 7 September 2012, which is 5,160 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.